About this trial
Objective cough reflex sensitivity testing is typically restricted to specialized research laboratories due to reliance on expensive dosimeter-controlled aerosol delivery systems. This study evaluates the feasibility and reliability of a low-cost alternative method using a handheld nebulizer for citric acid cough challenge testing. Healthy adult participants will complete cough reflex sensitivity testing using both a standard dosimeter-controlled nebulizer system (Cosmed QuarkSpiro) and a handheld nebulizer (DeVilbiss 45). The study will compare cough threshold outcomes between methods to determine whether handheld nebulizer-based testing produces comparable and reproducible measurements.
Eligibility criteria
Qualifiers
Healthy adults at least 18 years of age
Consent to audio/video recording of the research sessions for research purposes
Spirometry testing results obtained by study team on same day of first testing session with FEV1/FVC ratio and FEV1 percent predicted values of at least 0.70
Disqualifiers
Pregnant or trying to become pregnant (if capable of becoming pregnant- a urine pregnancy test will be provided onsite and a negative result must be obtained prior to the first testing session)
Smoking of any substance in the last six months
Diagnosed or suspected pulmonary disease (e.g., asthma, COPD)
History of chronic cough
Trial design
Treatments tested in this trial
- Cosmed QuarkSpiro Dosimeter-Controlled Nebulizer
- DeVilbiss 45 Handheld Nebulizer
Treatment groups
Sponsors and collaborators
University of Montana
Lead sponsor
National Institute of General Medical Sciences (NIGMS)
Collaborator